Antigoni Morou1, Brent E Palmer, Daniel E Kaufmann. 1. aDepartement of Medicine and Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), University of Montreal, Montréal, Quebec, Canada bUniversity of Colorado, Research Complex 2, room 10007 (B164), 12700 E 19th Ave, Aurora, Colorado 80045 USA. cThe Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: To describe recent advances in the understanding of virus-specific CD4 T cell dysfunction in chronic viral infections, with an emphasis on HIV disease. We highlight features that are distinctive for CD4 T cells, as opposed to their CD8 T cell counterparts. RECENT FINDINGS: CD4 T cell activation and differentiation are tightly controlled. Regulation of these processes depends on the context of initial encounter of the naïve CD4 T cell with the cognate antigen and on ongoing external cues to the antigen-experienced CD4 T cell, in particular the inflammatory environment, which is prominent in HIV infection. Virus-specific CD4 T cell dysfunction results from a combination of an exhaustion program and skewing in T helper lineage differentiation which impact function. The CD4 and CD8 T cell exhaustion programs present similarities and distinct features. The sets of inhibitory coreceptors expression differ, although programmed-death 1 (PD-1) and T cell immunoglobulin mucin-3 (Tim-3) are upregulated on both HIV-specific CD4 and CD8 T cells, cytotoxic T-lymphocyte antigen 4 (CTLA-4) is largely specific to CD4 T cells, whereas 2B4 and CD160 are biased toward CD8 T cells. SUMMARY: Understanding the molecular basis of HIV-specific CD4 T cell exhaustion and identifying key differences with CD8 T cell impairment will be critical to design effective therapeutic and preventive immunotherapies against HIV.
PURPOSE OF REVIEW: To describe recent advances in the understanding of virus-specific CD4 T cell dysfunction in chronic viral infections, with an emphasis on HIV disease. We highlight features that are distinctive for CD4 T cells, as opposed to their CD8 T cell counterparts. RECENT FINDINGS:CD4 T cell activation and differentiation are tightly controlled. Regulation of these processes depends on the context of initial encounter of the naïve CD4 T cell with the cognate antigen and on ongoing external cues to the antigen-experienced CD4 T cell, in particular the inflammatory environment, which is prominent in HIV infection. Virus-specific CD4 T cell dysfunction results from a combination of an exhaustion program and skewing in T helper lineage differentiation which impact function. The CD4 and CD8 T cell exhaustion programs present similarities and distinct features. The sets of inhibitory coreceptors expression differ, although programmed-death 1 (PD-1) and T cell immunoglobulin mucin-3 (Tim-3) are upregulated on both HIV-specific CD4 and CD8 T cells, cytotoxic T-lymphocyte antigen 4 (CTLA-4) is largely specific to CD4 T cells, whereas 2B4 and CD160 are biased toward CD8 T cells. SUMMARY: Understanding the molecular basis of HIV-specific CD4 T cell exhaustion and identifying key differences with CD8 T cell impairment will be critical to design effective therapeutic and preventive immunotherapies against HIV.
Authors: Mathieu F Chevalier; Boris Jülg; Augustine Pyo; Michael Flanders; Srinika Ranasinghe; Damien Z Soghoian; Douglas S Kwon; Jenna Rychert; Jeffrey Lian; Matthias I Muller; Sam Cutler; Elizabeth McAndrew; Heiko Jessen; Florencia Pereyra; Eric S Rosenberg; Marcus Altfeld; Bruce D Walker; Hendrik Streeck Journal: J Virol Date: 2010-11-03 Impact factor: 5.103
Authors: Filippos Porichis; Douglas S Kwon; Jennifer Zupkosky; Daniel P Tighe; Ashley McMullen; Mark A Brockman; David F Pavlik; Marta Rodriguez-Garcia; Florencia Pereyra; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann Journal: Blood Date: 2011-06-07 Impact factor: 22.113
Authors: Jacques Thèze; Lisa A Chakrabarti; Benoît Vingert; Filippos Porichis; Daniel E Kaufmann Journal: Clin Immunol Date: 2011-08-04 Impact factor: 3.969
Authors: Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker Journal: Nature Date: 2006-08-20 Impact factor: 49.962
Authors: Laura M Fahey; Elizabeth B Wilson; Heidi Elsaesser; Chris D Fistonich; Dorian B McGavern; David G Brooks Journal: J Exp Med Date: 2011-05-02 Impact factor: 14.307
Authors: Rafael A Cubas; Joseph C Mudd; Anne-Laure Savoye; Matthieu Perreau; Julien van Grevenynghe; Talibah Metcalf; Elizabeth Connick; Amie Meditz; Gordon J Freeman; Guillermo Abesada-Terk; Jeffrey M Jacobson; Ari D Brooks; Shane Crotty; Jacob D Estes; Giuseppe Pantaleo; Michael M Lederman; Elias K Haddad Journal: Nat Med Date: 2013-03-10 Impact factor: 53.440
Authors: Michael Quigley; Florencia Pereyra; Björn Nilsson; Filippos Porichis; Catia Fonseca; Quentin Eichbaum; Boris Julg; Jonathan L Jesneck; Kathleen Brosnahan; Sabrina Imam; Kate Russell; Ildiko Toth; Alicja Piechocka-Trocha; Douglas Dolfi; Jill Angelosanto; Alison Crawford; Haina Shin; Douglas S Kwon; Jennifer Zupkosky; Loise Francisco; Gordon J Freeman; E John Wherry; Daniel E Kaufmann; Bruce D Walker; Benjamin Ebert; W Nicholas Haining Journal: Nat Med Date: 2010-10-03 Impact factor: 53.440
Authors: Charlly Kao; Kenneth J Oestreich; Michael A Paley; Alison Crawford; Jill M Angelosanto; Mohammed-Alkhatim A Ali; Andrew M Intlekofer; Jeremy M Boss; Steven L Reiner; Amy S Weinmann; E John Wherry Journal: Nat Immunol Date: 2011-05-29 Impact factor: 25.606
Authors: Peiyuan Lu; Benjamin A Youngblood; James W Austin; Ata Ur Rasheed Mohammed; Royce Butler; Rafi Ahmed; Jeremy M Boss Journal: J Exp Med Date: 2014-03-03 Impact factor: 14.307
Authors: Filippos Porichis; Meghan G Hart; Alexandra Massa; Holly L Everett; Antigoni Morou; Jonathan Richard; Nathalie Brassard; Maxime Veillette; Muska Hassan; Ngoc Le Ly; Jean-Pierre Routy; Gordon J Freeman; Mathieu Dubé; Andrés Finzi; Daniel E Kaufmann Journal: J Immunol Date: 2018-06-22 Impact factor: 5.422
Authors: Andrej Spec; Yuichiro Shindo; Carey-Ann D Burnham; Strother Wilson; Enyo A Ablordeppey; Evan R Beiter; Katherine Chang; Anne M Drewry; Richard S Hotchkiss Journal: Crit Care Date: 2016-01-20 Impact factor: 9.097
Authors: Rémi Fromentin; Wendy Bakeman; Mariam B Lawani; Gabriela Khoury; Wendy Hartogensis; Sandrina DaFonseca; Marisela Killian; Lorrie Epling; Rebecca Hoh; Elizabeth Sinclair; Frederick M Hecht; Peter Bacchetti; Steven G Deeks; Sharon R Lewin; Rafick-Pierre Sékaly; Nicolas Chomont Journal: PLoS Pathog Date: 2016-07-14 Impact factor: 6.823